Stockholders' (Deficit) Equity - November 2023 Equity Offering and Warrant Issuance (Details) - USD ($) |
9 Months Ended | ||
---|---|---|---|
Oct. 31, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
Stockholders' (Deficit) Equity | |||
Net cash proceeds after deducting underwriter discount and fees | $ 12,466,165 | $ 8,571,191 | |
November 2023 Equity Offering and Warrant Issuance | |||
Stockholders' (Deficit) Equity | |||
Issuance of common stock | 1,250,000 | ||
Number of shares which may be purchased with warrants | 1,250,000 | ||
Exercise price of warrants | $ 9.00 | ||
Term of warrants (in years) | 5 years | ||
Net cash proceeds after deducting underwriter discount and fees | $ 6,830,000 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|